Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: HIV Med. 2012 Feb 2;13(6):358–366. doi: 10.1111/j.1468-1293.2011.00988.x

Table 2.

Log hormone levels and coronary artery calcium (CAC) presence, log intima-media thickness (IMT), and lesion presence in HIV-infected and HIV-uninfected participants

CAC presence
OR (95% CI)
Log IMT
β (P-value)
Lesion presence
OR (95% CI)
Log FT 1.28 (0.80, 2.05) −0.0003 (0.98) 0.87 (0.55, 1.38)
HIV-infected/HIV-uninfected 1.44 (0.92, 2.24) −0.004 (0.75) 1.69 (1.06, 2.71)
Age 1.16 (1.12, 1.20) 0.01 (<0.0001) 1.10 (1.06, 1.13)
BMI 1.04 (0.99, 1.09) 0.01 (<0.0001) 1.01 (0.96, 1.06)
Race (Black) 0.46 (0.27, 0.79) 0.06 (<0.0001) 0.775 (0.45, 1.33)
Log HOMA-IR 1.03 (0.72, 1.47) −0.01 (0.29) 0.974 (0.68, 1.40)
Current smoker (yes/no) 2.44 (1.50, 4.00) −0.01 (0.69) 1.942 (1.19, 3.17)
LDL cholesterol ≥160 mg/dL 1.84 (1.03, 3.29) 0.01 (0.44) 1.05 (0.56, 1.97)
HDL cholesterol ≤40 mg/dL 1.36 (0.87, 2.10) −0.01 (0.68) 1.08 (0.68, 1.70)
Hypertension (yes/no) 1.28 (0.84, 1.95) 0.04 (0.002) 1.49 (0.97, 2.29)
Lipid-lowering agent use 1.27 (0.79, 2.06) 0.02 (0.24) 1.67 (1.02, 2.72)

BMI, body mass index; CI, confidence interval; FT, free testosterone; HDL, high-density lipoprotein; HOMA-IR, homeostatic model assessment of insulin resistance; LDL, low-density lipoprotein; OR, odds ratio.